clindamycin phosphate NDC 59762-3744

NDC codes

FDA NDC Directory

Product NDC (as listed)59762-3744Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59762-3744Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59762-3744-1	59762374401	1 BOTTLE in 1 CARTON (59762-3744-1) / 60 mL in 1 BOTTLEMarketed from May 31, 1989

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): clindamycin phosphate
Generic name (nonproprietary): clindamycin phosphate
Active ingredients: Clindamycin phosphate — 10 mg/mL
Dosage form: Lotion
Route: Topical
Labeler: Mylan Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 050600
Marketing start: May 31, 1989
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 59762-3744_d4cce371-d34f-42f1-8cd4-0f154115db84SPL ID d4cce371-d34f-42f1-8cd4-0f154115db84SPL set ID f7480256-8b32-419a-8983-e2c413040dbaRxCUI 197519, 309333, 2676585UNII EH6D7113I8UPC 0359762372826
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459762374401 followed by a unit qualifier and the quantity

Package 59762-3744-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 12, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin phosphate topical solution, clindamycin phosphate topical gel and clindamycin phosphate topical lotion are indicated in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea and pseudomembranous colitis, the physician should consider whether other agents are more appropriate (see CONTRAINDICATIONS , WARNINGS and ADVERSE REACTIONS ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 050600

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 050600
Product	Strength	Form · route	Labeler	Product NDC
Cleocin Tclindamycin phosphate	Clindamycin phosphate 10 mg/mL	LotionTopical	Pharmacia & Upjohn Company LLC	0009-3329